Genix Pharmaceuticals Statistics
Total Valuation
GENPF has a market cap or net worth of 897,452. The enterprise value is 1.64 million.
| Market Cap | 897,452 |
| Enterprise Value | 1.64M |
Important Dates
The next estimated earnings date is Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 61.22M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 32.37% |
| Owned by Institutions (%) | n/a |
| Float | 33.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18,315.34 |
| PB Ratio | -0.87 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -25.63 |
| EV / Sales | n/a |
| EV / EBITDA | 10.83 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.94 |
| Debt / FCF | n/a |
| Interest Coverage | -2.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -163.17% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 23.79% |
| Weighted Average Cost of Capital (WACC) | 9.34% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -16 |
| Employee Count | 4,000 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.75% in the last 52 weeks. The beta is 0.49, so GENPF's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -64.75% |
| 50-Day Moving Average | 0.10 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 44.02 |
| Average Volume (20 Days) | 15,517 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.23 |
Income Statement
In the last 12 months, GENPF had revenue of 49 and -64,135 in losses. Loss per share was -0.00.
| Revenue | 49 |
| Gross Profit | -132,226 |
| Operating Income | -245,127 |
| Pretax Income | -64,135 |
| Net Income | -64,135 |
| EBITDA | 149,604 |
| EBIT | -245,127 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 3,350 in cash and 739,082 in debt, with a net cash position of -735,732.
| Cash & Cash Equivalents | 3,350 |
| Total Debt | 739,082 |
| Net Cash | -735,732 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -1.03M |
| Book Value Per Share | -0.02 |
| Working Capital | -1.03M |
Cash Flow
| Operating Cash Flow | -96,371 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -500,259.18% |
| Pretax Margin | -130,887.76% |
| Profit Margin | n/a |
| EBITDA Margin | 304,476.47% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GENPF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -7.15% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GENPF has an Altman Z-Score of -746.35. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -746.35 |
| Piotroski F-Score | n/a |